Patents
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
11/1995
11/07/1995US5464811 Benzene derivatives substituted with heterocyclic ring and herbicides containing same as active ingredients
11/02/1995WO1995029165A2 Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors
11/02/1995WO1995029147A1 A process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives
11/02/1995WO1995029142A1 Method of separating optical isomers
11/02/1995EP0679637A1 Acetaldehyd derivatives, process for their preparation and their use
11/02/1995EP0679633A1 Diaminobenzene derivatives and polyimides prepared therefrom
11/02/1995EP0333758B1 Control of molecular weight and end group functionality of polymers
11/02/1995CA2188759A1 A process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives
11/02/1995CA2188748A1 Benzocycloalkylazolethione derivatives
10/1995
10/31/1995US5463097 Enantioselective hydrogenation catalysts
10/31/1995US5463051 Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
10/31/1995US5462826 Charge transporting materials and electrophotographic photoconductors using the same
10/26/1995WO1995028392A1 Chelant compounds
10/26/1995WO1995028157A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
10/26/1995CA2187773A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
10/26/1995CA2187528A1 Chelant compounds
10/24/1995US5461175 Method for separating enantiomers of aryloxipropanolamine derivatives, and chiral solid-phase chromatography material for use in the method
10/24/1995US5461148 Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
10/24/1995US5461147 Cyclizing secondary amine-containing or carbamate-containing alcohol, reducing with hydride, treating with acetal compound, treating with alkoxide
10/24/1995US5460605 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
10/24/1995CA1337425C Substituted (n-ethylamino)methyl-1,2,3,4- tetrahydronaphthalene compounds having alpha-2 adrenergic antagonist activity
10/18/1995EP0677507A1 Process for producing acid-addition salt of z-isomer of triphenylethylene compound
10/18/1995EP0677291A2 Composition and method containing optically pure (S) metoprolol
10/18/1995EP0676960A1 Cycloalkyl amine bis-aryl squalene synthase inhibitors
10/18/1995EP0601063B1 Fluorine-containing diamines, polyamides, and polyimides
10/17/1995US5459145 Calcium independent camp phosphodiesterase inhibitor antidepressant
10/17/1995CA1337357C Polyether polyols based on aromatic diamines and polyamines, a process for their preparation, and their use for polyurethane and polyisocyanurate plastics
10/12/1995WO1995026720A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/12/1995CA2186604A1 Permanently ionic derivatives of steroid hormones and their antagonists
10/11/1995EP0675872A1 Quaternary fatty-acid triethanolamine ester salts.
10/11/1995CN1110048A Use of 3-substituted para-aminophenols for dyeing keratinous fibres and novel substituted 3-para-aminophenols
10/11/1995CN1109868A Process for the preparation of 4-methoxy-2,2',6'-trimethyldiphenylamine
10/10/1995US5457232 Pyrenylamine derivatives having unsaturated bond
10/05/1995WO1995026327A1 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists
10/03/1995US5455271 Using aromatic amine derivitives as mosquito insecticide
10/03/1995US5455260 Anticholesterol agents; reduction of serum cholesterol without reducing mevalonic metabolite synthesis; side effect
10/03/1995US5455259 Compounds for the treatment of neurodegenerative disorders
10/03/1995US5454973 Stable dispersible mineral acid slurry of benzidine derivatives
10/03/1995CA1337193C Muscarinic receptor antagonists
09/1995
09/28/1995WO1995025713A1 Process for producing esterquats
09/28/1995WO1995025710A1 Electrophilic substitution of triphenylene-based discotic liquid crystals
09/27/1995EP0643758A4 Poly(vinyl ether) amines and fuel compositions containing the same.
09/26/1995US5453541 Method of preparing 4-aminodiphenylamine
09/26/1995CA1337141C Polyperfluoroaminoethers
09/26/1995CA1337128C Propanamine derivatives
09/21/1995WO1995021612A3 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
09/21/1995WO1995019974A3 Calixarene-based compounds having antibacterial, antifungal, anticancer-hiv activity
09/20/1995EP0672646A1 Process for producing beta-nitro-enamines and intermediates thereof
09/20/1995EP0672031A1 Catechol diethers as selective pde iv? inhibitors
09/19/1995US5451608 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovasular system, processes for their preparation and pharmaceutical compositions containing them
09/19/1995US5451596 Cycloalkyl amine bis-aryl squalene synthase inhibitors
09/13/1995EP0671397A1 Alkylaminoindanes compounds, processes for their preparation and pharmaceutical compositions containing them
09/13/1995EP0670675A1 An aqueous alkaline metal working fluid containing a primary amine
09/13/1995EP0643759A4 Poly(alkylene ether) hydroxy (oxypropylene) amines and fuel compositions containing the same.
09/12/1995US5449785 Cyclohexane derivatives
09/12/1995US5449580 Organic photosensitive material for electrophotography
09/12/1995CA2144288A1 Alkylaminoindans compounds; process for preparing the same and pharmaceutical compositions containing them
09/05/1995CA1336911C Serotonin antagonists
08/1995
08/31/1995WO1995023127A1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity
08/29/1995US5446205 Functionalized fluoropolyethers
08/29/1995US5446068 1-phenyl-3-phenyl-2-propyne-1-ones as calcium uptake inhibitors
08/29/1995CA1336839C Process for the preparation of 2,2'-oxybis [n,n-dimethylethanamine]
08/29/1995CA1336838C Process for the coproduction of anilines and oxamides
08/24/1995WO1995022555A1 Displacement chromatography of proteins using low molecular weight displacers
08/24/1995WO1995022520A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors
08/24/1995CA2182792A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors
08/23/1995EP0667852A1 Novel 3,3-diphenylpropylamines, their use and preparation
08/23/1995EP0667769A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
08/23/1995CN1107138A Systesis and application for diaryloxy-propyl amine compound
08/23/1995CN1107137A Novel carboxylate derivatives exhibiting phospholipase A2 inhibitery a ctivity
08/22/1995US5444165 Reacting diamino compound with unsaturated dicarboxylic anhydride to form amic acid intermediate, catalytic dehydration-ring closing; solvent soluble, low water absorption and flexibility
08/22/1995US5444099 Molding materials; odorless, non irritating to skin
08/22/1995US5443596 Keratinous fiber dyeing compositions and processes utilizing oxidation dye precursors in combination with dimethoxy meta-aminophenol couplers
08/17/1995WO1995021825A1 6-aryl-(methyl- or methylidone)-quinoline derivatives as voltage-gated potassium channel blockers
08/17/1995WO1995021824A1 6-aryl-(methyl- or methylidene)-quinol-2-one derivatives as voltage gated potassium channel blockers
08/17/1995WO1995021823A1 6-aryl-(methyl- or methylidene)-quinoline derivatives as voltage-gated potassium channel blockers
08/17/1995WO1995021813A1 Cyclohexane derivatives as voltage-gated potassium channel blockers
08/17/1995WO1995021811A1 Novel benzylaminoethoxybenzene derivative, process for producing the same, and use thereof
08/17/1995WO1995021612A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/17/1995WO1995021603A1 2-fluoro-6-nitroanilines
08/17/1995DE4404198A1 2-Fluor-6-nitroaniline 2-fluoro-6-nitroaniline
08/17/1995DE4402695A1 Verfahren zur Verminderung des Restgehaltes an freiem Alkylierungsmittel in wäßrigen Lösungen stickstoffhaltiger Tenside A process for reducing the residual content of free alkylating agent in aqueous solutions of nitrogen-containing surfactants
08/17/1995CA2183077A1 Cyclohexane derivatives as voltage-gated potassium channel blockers
08/17/1995CA2182680A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/17/1995CA2160019A1 Novel benzylaminoethoxybenzene derivatives, production thereof and use thereof
08/16/1995EP0666840A1 Benzylamine derivatives
08/15/1995US5442122 Dibenzosuberyl and dibenzosuberenyl derivatives
08/15/1995US5441985 Administring tomoxetin for incontinence; negligible anti-cholinergic effect
08/10/1995WO1995021176A1 Hydrogenation catalyst, process for the preparation thereof and hydrogenation process
08/10/1995WO1995021151A1 Process for the hydrogenation of imines
08/09/1995EP0656883A4 Cationic lipids.
08/09/1995EP0461237B1 Use of 9,10-dihydrophenanthrene derivatives to prepare an antitumoral drug, and novel derivatives thereof
08/09/1995CN1106396A Intermediates useful in the production of aromatic amino-alcohol derivatives having anti-diabetic an21443/o1besity properties
08/08/1995US5440060 Surface-active compounds based on alkoxylated fatty amines
08/08/1995US5440049 Process for producing enyne derivatives
08/03/1995WO1995020640A1 Detergent mixtures
08/03/1995WO1995020639A1 Aqueous solutions of esterquats
08/03/1995WO1995020578A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
08/03/1995WO1995020566A1 Method of reducing the residual content of free alkylation agent in aqueous solutions of nitrogen-containing surfactants
08/03/1995DE4402527A1 Wäßrige Lösungen von Esterquats Aqueous solutions of Esterquats